KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio: 2011-2023

Historic Interest Coverage Ratio for Supernus Pharmaceuticals (SUPN) over the last 12 years, with Jun 2023 value amounting to -19.33.

  • Supernus Pharmaceuticals' Interest Coverage Ratio fell 408.31% to -19.33 in Q2 2023 from the same period last year, while for Jun 2023 it was 3.56, marking a year-over-year increase of 6.79%. This contributed to the annual value of -2.18 for FY2023, which is 133.44% down from last year.
  • According to the latest figures from Q2 2023, Supernus Pharmaceuticals' Interest Coverage Ratio is -19.33, which was down 661.94% from 3.44 recorded in Q1 2023.
  • Supernus Pharmaceuticals' 5-year Interest Coverage Ratio high stood at 21.54 for Q4 2022, and its period low was -19.33 during Q2 2023.
  • For the 3-year period, Supernus Pharmaceuticals' Interest Coverage Ratio averaged around 2.70, with its median value being 2.80 (2023).
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Interest Coverage Ratio surged by 1,996.02% in 2022, and later tumbled by 408.31% in 2023.
  • Supernus Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at 7.07 in 2019, then declined by 0.17% to 7.05 in 2020, then slumped by 85.43% to 1.03 in 2021, then skyrocketed by 1,996.02% to 21.54 in 2022, then slumped by 408.31% to -19.33 in 2023.
  • Its last three reported values are -19.33 in Q2 2023, 3.44 for Q1 2023, and 21.54 during Q4 2022.